Valuation: Astellas Pharma Inc.

Market Cap 4,23700Cr 2.67TCr 2.31TCr 2.16TCr 1.97TCr 3.72TCr 2,54300Cr 3.77TCr 25TCr 9.93TCr 1,27200Cr 10TCr 9.79TCr P/E 2027 *
11.8x
P/E 2028 * 12.4x
Enterprise Value 4,24800Cr 2.67TCr 2.31TCr 2.16TCr 1.98TCr 3.73TCr 2,55000Cr 3.78TCr 25TCr 9.95TCr 1,27500Cr 10TCr 9.82TCr EV / Sales 2027 *
1.86x
EV / Sales 2028 * 1.82x
Free-Float
98.88%
Yield 2027 *
3.4%
Yield 2028 * 3.51%
1 day+1.55%
1 week+7.31%
Current month+7.31%
1 month+10.55%
3 months+2.74%
6 months-5.63%
Current year+12.90%
1 week 2,125
Extreme 2125
2,377
1 month 2,109
Extreme 2109
2,377
Current year 2,041
Extreme 2041
2,717
1 year 1,557.5
Extreme 1557.5
2,717
3 years 1,243.5
Extreme 1243.5
2,717
5 years 1,243.5
Extreme 1243.5
2,717
10 years 1,243.5
Extreme 1243.5
2,717
Manager TitleAgeSince
Chief Executive Officer 63 10/02/2023
Director of Finance/CFO 54 01/11/2023
Compliance Officer - 01/04/2025
Director TitleAgeSince
Chairman 66 10/02/2023
Director/Board Member 63 01/06/2019
Director/Board Member 58 01/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.55%+7.31%+46.27%+8.49% 2.65TCr
+3.90%+8.11%+90.85%+132.54% 1,05700Cr
+0.99%+2.04%+49.36%+50.79% 62TCr
+0.78%-0.31%+23.01%+61.35% 43TCr
+1.58%+5.51%+51.42%+40.47% 36TCr
+0.65%+0.16%+34.81%+39.85% 30TCr
+0.79%-5.08%+9.78%+7.23% 25TCr
+1.52%+8.73%+44.49%+57.19% 22TCr
+0.34%-0.11%-5.23%-51.54% 21TCr
-0.11%+1.55%+10.55%+66.48% 17TCr
Average +0.81%+3.68%+35.53%+41.28% 36.47TCr
Weighted average by Cap. +1.04%+4.02%+49.36%+65.79%

Financials

2027 *2028 *
Net sales 2,28800Cr 1.44TCr 1.25TCr 1.17TCr 1.06TCr 2.01TCr 1,37300Cr 2.04TCr 14TCr 5.36TCr 69TCr 5.41TCr 5.29TCr 2,10100Cr 1.32TCr 1.14TCr 1.07TCr 977.77Cr 1.84TCr 1,26100Cr 1.87TCr 13TCr 4.92TCr 63TCr 4.96TCr 4.86TCr
Net income 34TCr 215.96Cr 186.96Cr 174.75Cr 159.71Cr 300.97Cr 21TCr 305.68Cr 2.05TCr 804.1Cr 10TCr 810.92Cr 793.24Cr 32TCr 203.85Cr 176.47Cr 164.95Cr 150.76Cr 284.09Cr 19TCr 288.53Cr 1.93TCr 758.99Cr 9.73TCr 765.44Cr 748.74Cr
Net Debt 1.11TCr 7Cr 6.06Cr 5.66Cr 5.18Cr 9.75Cr 667.57Cr 9.91Cr 66Cr 26Cr 333.97Cr 26Cr 26Cr -42TCr -262.87Cr -227.56Cr -212.7Cr -194.4Cr -366.33Cr -25TCr -372.06Cr -2.49TCr -978.73Cr -13TCr -987.04Cr -965.51Cr
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
14,099
Date Price Change Volume
10/26/10 JP¥2,363.00 +1.55% 62,87,500
07/26/07 JP¥2,327.00 +1.68% 80,01,800
06/26/06 JP¥2,288.50 +6.00% 1,03,52,900
05/26/05 JP¥2,159.00 -0.44% 53,88,800
04/26/04 JP¥2,168.50 -0.34% 67,19,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
2,363.00JPY
Average target price
2,413.08JPY
Spread / Average Target
+2.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4503 Stock